Rania Gamal

Rania Gamal

Auto-generated profile, based on publicly available information

Rania Gamal

Obstetrics and Gynecology department, Ain Shams University, Cairo, Egypt

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2023 in The Journal of Obstetrics and Gynecology of India
Verified
Journal Article
Closed access
PDF file
RERania Gamal Anwar El-Skaan
Rania Gamal Anwar El-Skaan
RARehab Mohamed Abdelrahman
Rehab Mohamed Abdelrahman
AHAhmed Mohamed Abdelhamed Hassan
Ahmed Mohamed Abdelhamed Hassan

29 January 2024 in Ultrasound
Verified
Journal Article
Closed access
MEMortada Elsayed
Mortada Elsayed
MAMohamed I Amer
Mohamed I Amer
RGRania Gamal
Rania Gamal
AHAly Haggag
Aly Haggag
AMAhmed R Mashaly
Ahmed R Mashaly
WEWalaa Elsayed
Walaa Elsayed
Introduction: The uterine cavity is a potential space with limited methods for evaluating its volume, limiting the evaluation of interventions’ effectiveness in various uterine conditions. This study aims to objectively measure the uterine cavity volume using sonohysterography coupled with a Foley catheter to provide a normative model of age and parity-related uterine cavity volume. Methods: The research included 35 women (group 1) with a total abdominal hysterectomy and 150 women (group 2) who underwent sonohysterography for various gynecologic indications. Saline infusion sonography was administered to all patients. The most common shape obtained after the saline infusion was taken to measure the uterine cavity’s dimensions and volume. The uterine cavity volumes, as measured by sonohysterography, and the volumes of saline injected after the hysterectomy were compared. Results: A significant association exists between uterine cavity volumes measured by sonohysterography and true volumes measured immediately after hysterectomy ( p = 0.001). The association between uterine cavity volume measured by sonohysterography and using only a Foley catheter balloon was statistically insignificant ( p = 0.13). A statistically significant positive association was observed between the uterine cavity volume and the patient’s age and parity ( p ⩽ 0.05). Conclusion: Measuring the uterine cavity volume using a paediatric Foley catheter balloon coupled with sonohysterography offers an objective approach to measuring a normal (without gross pathologies) uterus volume. This technique would improve the diagnostic accuracy and the management of women with distinct uterine cavity morphologies.

11 May 2026 in The Journal of Headache and Pain
Verified
Journal Article
Open access
RSRadwa Soliman
Radwa Soliman
YMYoussra Gadallah Mahfouz
Youssra Gadallah Mahfouz
RERania Gamal Anwar El-Skaan
Rania Gamal Anwar El-Skaan
WMWarda Abdelfattah Shehata Mohamed
Warda Abdelfattah Shehata Mohamed
Background: The interplay between Antiphospholipid syndrome (APS) and migraine is very controversial; migraine is believed to be the most common neurologic symptom in APS, and there are claims that migraineurs have abnormally high Antiphospholipid antibodies (aPL), yet the reports differ widely. Nevertheless, APS could lead to various other types of headaches; both primary and secondary, leaving patients susceptible to exacerbation of symptoms, overlapping of headaches, and atypical presentations. Aim of the work: To describe types and characteristics of headache in a cohort of patients with antiphospholipid syndrome (APS) in comparison to healthy controls. And investigate their possible relation with antiphospholipid antibodies (aPL) and MRI brain findings in patients with APS. Methods: We recruited 76 patients with APS consecutively, between February 2024 and August 2025. From Ain shams university hospital; neurology, internal medicine, and obstetric and gynecology departments, along with 60 matched controls. Patients and controls underwent neurological examination and were evaluated for headache according to the International Headache Society criteria (IHS), Impact and severity were assessed by Migraine Disability Assessment (MIDAS) and Headache Impact Test (HIT). All participants had a brain MRI. Results: A total of 76 patients; 70 females and 6 males, mean age for patients at presentation was 35 ± 8.73 years; mean disease duration was 5 ± 3 years; mean Body mass index (BMI) was 22.38 ± 1.46. Headache was reported by 87% of patients; of which 16 patients suffered secondary type headaches (21%); and 50 patients had primary headaches (65.7%); with migraine being the most common (35%). Anticardiolipin (ACL) antibodies were the most common aPL detected (76.4%) in APS patients. MRI brain was normal in 86% of APS patients with primary headaches, Meanwhile, APS patients with triple positive antibodies showed significantly more abnormal MRI findings ( p = 0.04). Headache severity was significantly more in APS patients ( p = 0.04) Factors affecting headache severity were APS disease duration, BMI, triple aPL positivity ( p =  0.03, 0.00, 0.02 respectively). Conclusion: Primary and secondary types of headaches are frequently reported in Patients with APS, primary headache being more common; migraine in particular. APS patients had significantly more severe headaches. MRI brain was normal in the majority of APS patients with primary headaches and healthy controls. Yet, patients with triple positive antibodies showed more abnormal MRI findings. APS disease duration, BMI, triple aPL were independent factors for headache severity.

16 January 2024 in Qeios Preprints
Verified
Preprint
Open access
PDF file
EME. Ahmed Mortada
E. Ahmed Mortada
RGRania Gamal
Rania Gamal
ISIsraa Bahaa Hassan Sherif
Israa Bahaa Hassan Sherif
AMAliaa Mohamed Maaty
Aliaa Mohamed Maaty
BACKGROUND: The evolution of sonohysterography over the past years has contributed significantly to the assessment of uterine cavity. Saline infused sonohysterography (SHG) may be recommended as an alternative to Diagnostic Hysteroscopy for the assessment of the uterine cavity and uterine scar in women with previous Cesarean Section. Three-dimensional (3D) ultrasonography that enhances visualization of the lower uterine segment (LUS), myometrial thickness and the size of uterine diverticulum is a more recent tool used to diagnose post-cesarean section uterine diverticulum. OBJECTIVE: To compare accuracy of three-dimensional transvaginal ultrasound versus the “gold standard” saline infused sonography for assessing the characteristics, frequency of caesarean scar defects in symptomatic patients with a history of cesarean section. PATIENTS AND METHODS: This study was conducted with 72 women. patients were recruited from the ultrasound unit underwent both threedimentional transvaginal ultrasound and saline infused sonohysterography. This study, conforming to the declaration of Helsinki, was approved by the ethical committee of Obstetrics and Gynecology department, Ain Shams University, ethical committee number FMASU M D 52 \2021. RESULTS: 3D transvaginal ultrasound and sonohysterography showed almost good agreement regarding prevalence of niche with kappa (κ) 0.780 with p-value (p<0.001). Both imaging modalities show statistically significant higher mean value of volume in SIS was 591.67±271.05 comparing to 3D TVUS was 444.36±219.42, with p-value (p=0.004). CONCLUSION: There is a substantial agreement between 3D TVUS and SIS in evaluating various niche characteristics, encompassing depth, length, width, volume, AMT and RMT. The data strongly supports the advantages of 3D TVUS over SIS for assessing Cesarean scar defects, commonly known as "Niche." These benefits encompass cost-effectiveness, improved time efficiency, enhanced patient tolerability, and heightened patient satisfaction associated with the 3D TVUS procedure.

30 October 2023 in medRxiv
Verified
Preprint
Open access
PDF file
AKAsmaa F Kasem
Asmaa F Kasem
HAHamdy B Alqenawy
Hamdy B Alqenawy
MEMarwa A Elgendi
Marwa A Elgendi
RARadwa R Ali
Radwa R Ali
RARania Hm Ahmed
Rania Hm Ahmed
ANAshraf Nabhan
Ashraf Nabhan
Objectives: We conducted an update of systematic review to assess the effects of corticosteroids vs placebo or no treatment for improving patient relevant outcomes in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome. Design: a systematic review and meta-analysis of randomized controlled trials. Data sources: CENTRAL, MEDLINE/PubMed, Web of Science, and Scopus from the date of inception of the databases to September 20, 2023. The reference lists of included studies and other systematic reviews were thoroughly searched. Eligibility criteria: We included randomized controlled trials that enrolled women with HELLP syndrome, whether antepartum or postpartum, to receive any corticosteroid versus placebo or no treatment. No restrictions on language or date of publication were made. Data extraction and synthesis: We used a dual independent approach for screening titles and abstracts, full text screening, data extraction and risk of bias assessment. Pairwise meta-analyses were conducted, where two or more studies met methodological criteria for inclusion. The Grading of Recommendations, Assessment, Development and Evaluation approach was used to assess certainty for the pre-specified important outcomes. Results: Fifteen trials (821 women) compared corticosteroids with placebo or no treatment. The effect of corticosteroids is uncertain for the primary outcome i.e., maternal death (risk ratio 0.77, 95% confidence interval 0.25 to 2.38, very low certainty evidence). The effect of corticosteroids is also uncertain for other important outcomes including pulmonary edema, dialysis, liver morbidity (hematoma, rupture, and failure), or perinatal death because of very low certainty evidence. Low certainty evidence suggests that corticosteroids have little or no effect on the need for platelet transfusion (risk ratio 0.9821; 95% confidence interval 0.6031 to 1.5994) and may result in a slight reduction in acute renal failure (risk ratio 0.6658; 95% confidence interval 0.3965 to 1.1179) Conclusion: In women with HELLP syndrome, the effect of corticosteroids vs placebo or no treatment is uncertain for patient relevant outcomes including maternal death, maternal morbidity, and perinatal death.

1 December 2023 in Juniper Online Journal of Case Studies
Verified
Journal Article
Open access
PDF file
RERania G El-Skaan
Rania G El-Skaan
SHSalma T Hafez
Salma T Hafez
The uterine cervix cavernous hemangioma is a rare benign illness. There are just about 60 examples recorded in the literature. The majority of reported cases are around 35 years old. Cavernous hemangioma is most commonly found in the liver.